These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22339573)

  • 21. Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes.
    Cotter G; Metra M; Weatherley BD; Dittrich HC; Massie BM; Ponikowski P; Bloomfield DM; O'Connor CM
    Cardiology; 2010; 115(1):29-36. PubMed ID: 19844102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of BG9928, an adenosine A₁ receptor antagonist, in patients with congestive heart failure.
    Gottlieb SS; Ticho B; Deykin A; Abraham WT; Denofrio D; Russell SD; Chapman D; Smith W; Goldman S; Thomas I
    J Clin Pharmacol; 2011 Jun; 51(6):899-907. PubMed ID: 20926754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study.
    O'Connor CM; Fiuzat M; Lombardi C; Fujita K; Jia G; Davison BA; Cleland J; Bloomfield D; Dittrich HC; Delucca P; Givertz MM; Mansoor G; Ponikowski P; Teerlink JR; Voors AA; Massie BM; Cotter G; Metra M
    Circ Heart Fail; 2011 Nov; 4(6):724-32. PubMed ID: 21900185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data.
    Metra M; Cotter G; Senger S; Edwards C; Cleland JG; Ponikowski P; Cursack GC; Milo O; Teerlink JR; Givertz MM; O'Connor CM; Dittrich HC; Bloomfield DM; Voors AA; Davison BA
    Circ Heart Fail; 2018 May; 11(5):e004644. PubMed ID: 29748350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
    Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
    Gottlieb SS; Skettino SL; Wolff A; Beckman E; Fisher ML; Freudenberger R; Gladwell T; Marshall J; Cines M; Bennett D; Liittschwager EB
    J Am Coll Cardiol; 2000 Jan; 35(1):56-9. PubMed ID: 10636259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure.
    Liu LCY; Valente MAE; Postmus D; O'Connor CM; Metra M; Dittrich HC; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JGF; Givertz MM; Bloomfield DM; van Veldhuisen DJ; Hillege HL; van der Meer P; Voors AA
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):281-293. PubMed ID: 28656542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.
    van der Meer P; Postmus D; Ponikowski P; Cleland JG; O'Connor CM; Cotter G; Metra M; Davison BA; Givertz MM; Mansoor GA; Teerlink JR; Massie BM; Hillege HL; Voors AA
    J Am Coll Cardiol; 2013 May; 61(19):1973-81. PubMed ID: 23500313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure.
    Pang PS; Mehra M; Maggioni AP; Filippatos G; Middlebrooks J; Turlapaty P; Kazei D; Gheorghiade M;
    Am Heart J; 2011 Jun; 161(6):1012-23.e3. PubMed ID: 21641345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial.
    Metra M; Mentz RJ; Chiswell K; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Lazzarini V; Mansoor GA; Massie BM; Ponikowski P; Teerlink JR; Voors AA; O'Connor CM
    Eur J Heart Fail; 2015 Jan; 17(1):109-18. PubMed ID: 25431336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study.
    Gottlieb SS; Givertz MM; Metra M; Gergich K; Bird S; Jones-Burton C; Massie B; Cotter G; Ponikowski P; Weatherley B; O'Connor C; Dittrich H
    J Card Fail; 2010 Sep; 16(9):714-9. PubMed ID: 20797594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rolofylline (KW-3902): a new adenosine A1-receptor antagonist for acute congestive heart failure.
    Chaparro S; Dittrich HC; Tang WW
    Future Cardiol; 2008 Mar; 4(2):117-23. PubMed ID: 19804290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of tonapofylline in subjects with severe renal impairment and in elderly subjects.
    Li Z; Tenhoor C; Marbury T; Swan S; Zhu Y; Ticho B
    Int J Clin Pharmacol Ther; 2011 Sep; 49(9):563-70. PubMed ID: 21888869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beyond dyspnoea as an endpoint in acute heart failure trials.
    Gheorghiade M; Ruschitzka F
    Eur Heart J; 2011 Jun; 32(12):1442-5. PubMed ID: 21388991
    [No Abstract]   [Full Text] [Related]  

  • 35. Adenosine A1 antagonists and the cardiorenal syndrome.
    Gottlieb SS
    Curr Heart Fail Rep; 2008 Jun; 5(2):105-9. PubMed ID: 18765081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of Body Mass Index With Laboratory and Biomarkers in Patients With Acute Heart Failure.
    Streng KW; Ter Maaten JM; Cleland JG; O'Connor CM; Davison BA; Metra M; Givertz MM; Teerlink JR; Ponikowski P; Bloomfield DM; Dittrich HC; Hillege HL; van Veldhuisen DJ; Voors AA; van der Meer P
    Circ Heart Fail; 2017 Jan; 10(1):. PubMed ID: 28069685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study.
    Greenberg B; Thomas I; Banish D; Goldman S; Havranek E; Massie BM; Zhu Y; Ticho B; Abraham WT
    J Am Coll Cardiol; 2007 Aug; 50(7):600-6. PubMed ID: 17692744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280.
    Dennissen FJ; Anglada-Huguet M; Sydow A; Mandelkow E; Mandelkow EM
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11597-11602. PubMed ID: 27671637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical therapy for acute decompensated heart failure: what recent clinical trials have taught us about diuretics and vasodilators.
    Marti C; Cole R; Kalogeropoulos A; Georgiopoulou V; Butler J
    Curr Heart Fail Rep; 2012 Mar; 9(1):1-7. PubMed ID: 21874282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.